Cargando…

β‐Cell senescence in the pathogenesis of type 2 diabetes

The prevalence of type 2 diabetes increases with aging, and the type 2 diabetes developing in the elderly is often accompanied by a gradual impairment of β‐cell function and reduced β‐cell mass along with aging. However, the contribution of β‐cell senescence to the pathogenesis of type 2 diabetes re...

Descripción completa

Detalles Bibliográficos
Autor principal: Imai, Junta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078132/
https://www.ncbi.nlm.nih.gov/pubmed/31618527
http://dx.doi.org/10.1111/jdi.13162
_version_ 1783507552190857216
author Imai, Junta
author_facet Imai, Junta
author_sort Imai, Junta
collection PubMed
description The prevalence of type 2 diabetes increases with aging, and the type 2 diabetes developing in the elderly is often accompanied by a gradual impairment of β‐cell function and reduced β‐cell mass along with aging. However, the contribution of β‐cell senescence to the pathogenesis of type 2 diabetes remains uncertain. In a recent Cell Metabolism article, Aguayo‐Mazzucato et al. described their efforts to identify the signatures of senescent β‐cells, and explored the role(s) of senescent β‐cells in type 2 diabetes.[Image: see text]
format Online
Article
Text
id pubmed-7078132
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-70781322020-03-19 β‐Cell senescence in the pathogenesis of type 2 diabetes Imai, Junta J Diabetes Investig Commentaries The prevalence of type 2 diabetes increases with aging, and the type 2 diabetes developing in the elderly is often accompanied by a gradual impairment of β‐cell function and reduced β‐cell mass along with aging. However, the contribution of β‐cell senescence to the pathogenesis of type 2 diabetes remains uncertain. In a recent Cell Metabolism article, Aguayo‐Mazzucato et al. described their efforts to identify the signatures of senescent β‐cells, and explored the role(s) of senescent β‐cells in type 2 diabetes.[Image: see text] John Wiley and Sons Inc. 2019-11-19 2020-03 /pmc/articles/PMC7078132/ /pubmed/31618527 http://dx.doi.org/10.1111/jdi.13162 Text en © 2019 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Commentaries
Imai, Junta
β‐Cell senescence in the pathogenesis of type 2 diabetes
title β‐Cell senescence in the pathogenesis of type 2 diabetes
title_full β‐Cell senescence in the pathogenesis of type 2 diabetes
title_fullStr β‐Cell senescence in the pathogenesis of type 2 diabetes
title_full_unstemmed β‐Cell senescence in the pathogenesis of type 2 diabetes
title_short β‐Cell senescence in the pathogenesis of type 2 diabetes
title_sort β‐cell senescence in the pathogenesis of type 2 diabetes
topic Commentaries
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078132/
https://www.ncbi.nlm.nih.gov/pubmed/31618527
http://dx.doi.org/10.1111/jdi.13162
work_keys_str_mv AT imaijunta bcellsenescenceinthepathogenesisoftype2diabetes